Zukunftsfonds Heilbronn Mergers and Acquisitions Summary

Family Office Profile

In the last 3 years, Zukunftsfonds Heilbronn has invested in 1 company.

Zukunftsfonds Heilbronn’s most common sectors for investment arelife science (34%) and medical products (17%) . The Firm’s most common investment types include growth capital (67%) and venture (9%).

In the last 3 years, Zukunftsfonds Heilbronn has exited 2 companies. The Firm’s most common exit type is trade sale (75%).

Join Mergr to view Zukunftsfonds Heilbronn’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity16
    • M&A Buy Activity12
    • M&A Sell Activity4
  • Total Sectors Invested 8
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Zukunftsfonds Heilbronn

Edisonstraße 19,
Heilbronn, 74076
Germany
+49 7131 873183-0
www.zf-hn.de
info@zf-hn.de

Zukunftsfonds Heilbronn is a family backed growth investor focused on emerging companies in the Heilbronn area of Germany. Zukunftsfonds Heilbronn was established in 2005 and is headquartered in Heilbronn, Germany.


Investment Criteria

Sectors of Interest: Automotive, Communications, Electronics, Energy Services and Equipment, Environmental, Healthcare Services, Information Technology, Life Science

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase, Venture

Geographic Preferences: Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 5 10
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.2/yr) # 11 - - - 1 - 12
Sell (0.4/yr) # 2 - - 2 - - 4
  16

Most Recent M&A

Company Date Value Type
PL BioScience GmbH 2020-10-12 - Growth Capital
Aachen, Germany · www.pl-bioscience.com
Medimetrics GmbH 2019-09-18 - Add-on Acquisition
Heilbronn, Germany · www.medimetrics.com
Medineering GmbH 2019-04-10 - Add-on Acquisition
Munich, Germany · www.medineering.de
Xenios AG 2016-10-31 - Add-on Acquisition
Heilbronn, Germany · www.xenios-ag.com
Medos Medizintechnik AG 2015-09-22 - Secondary Buyout
Stolberg, Germany · www.medos-ag.de
Schwarzer Cardiotek GmbH 2014-10-07 - Merger
Heilbronn, Germany · www.schwarzercardiotek.com
Medimetrics GmbH 2014-09-17 - Growth Capital
Heilbronn, Germany · www.medimetrics.com
Protagen Protein Services GmbH 2013-06-28 - Growth Capital
Dortmund, Germany · www.proteinservices.protagen.com
Compositence GmbH 2013-04-26 - Growth Capital
Leonberg, Germany · www.compositence.de
Echobot Media Technologies GmbH 2013-03-01 - Growth Capital
Karlsruhe, Germany · www.echobot.de
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 3 (30%) - 4 (33%) -
Medical Products 1 (10%) - 2 (17%) -
Engineering 1 (10%) - 1 (8%) -
Environmental 1 (10%) - 1 (8%) -
Manufacturing 1 (10%) - 1 (8%) -
Media 1 (10%) - 1 (8%) -
Software 1 (10%) - 1 (8%) -
Test/Measurement Equipment 1 (10%) - 1 (8%) -
Total 10 - 12 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Germany 10 (100%) - 12 (100%) -
Total 10 - 12 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 7 (70%) - 8 (67%) -
Buyout (LBO, MBO, MBI) 1 (10%) - 1 (8%) -
Merger 1 (10%) - 1 (8%) -
Secondary Buyout - - 1 (8%) -
Venture 1 (10%) - 1 (8%) -
Total 10 - 12 -

Exits by Deal Type

Type Total # Value
Trade Sale 2 (50%) -
Secondary Sale 1 (25%) -
Trade Sale - Public Company 1 (25%) -
Total 4 -

M&A Connections

Deals
Acquired from
Investor(s)
8%
1 (8%)
Exited to
Investor(s)
25%
1 (25%)
Strategic(s)
75%
3 (75%)

Investor Summary

Investor Type

Family Office

Size

Small

PE Assets

200M USD

Established

2005

Specialist/Generalist

Generalist

Leadership

Thomas Villinger

CEO & Founder

 Subscribe to unlock this and 171,700
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 161K M&A Transactions
  • 167K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 59K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal